VONMERA Trademark
Trademark Overview
On Tuesday, September 19, 2023, a trademark application was filed for VONMERA with the United States Patent and Trademark Office. The USPTO has given the VONMERA trademark a serial number of 79384291. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, November 20, 2024. This trademark is owned by Curocell Inc.. The VONMERA trademark is filed in the Pharmaceutical Products category with the following description:
Immunotherapeutic agents comprising pharmaceutical preparations for cellular and gene therapy; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for use in cell cultures for medical purposes; biological preparations for medical diagnosis; medicines for human purposes for treatment of cancer; diagnostic agents for pharmaceutical purposes; pharmaceutical preparations for medical purposes, namely, for treatment of cancer; anti-cancer preparations; antibody drugs, namely, antibodies for medical purposes
General Information
| Serial Number | 79384291 |
| Word Mark | VONMERA |
| Filing Date | Tuesday, September 19, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, November 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Immunotherapeutic agents comprising pharmaceutical preparations for cellular and gene therapy; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for use in cell cultures for medical purposes; biological preparations for medical diagnosis; medicines for human purposes for treatment of cancer; diagnostic agents for pharmaceutical purposes; pharmaceutical preparations for medical purposes, namely, for treatment of cancer; anti-cancer preparations; antibody drugs, namely, antibodies for medical purposes |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 1, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Curocell Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
Trademark Events
| Event Date | Event Description |
| Thursday, November 30, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, December 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 13, 2024 | ASSIGNED TO EXAMINER |
| Thursday, May 16, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, May 28, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, May 28, 2024 | REFUSAL PROCESSED BY MPU |
| Monday, June 17, 2024 | REFUSAL PROCESSED BY IB |
| Thursday, November 14, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 14, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 14, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, November 15, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 15, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 5, 2023 | APPLICATION FILING RECEIPT MAILED |
